Dog /

Breed profile · FDA CVM July 2026 extract

Spitz - German Pomeranian adverse-event record

Adverse-event filings for Spitz - German Pomeranian (Dog) in the FDA Center for Veterinary Medicine openFDA extract. Browse dog breeds, reactions, and outcomes below.

Verify with FDA CVM →
#23 of 510
by report volume (all breeds)
9,086
FDA CVM reports on file
4.9%
death-coded share of reports
#131 of 275
by death-coded share (≥50 reports)

How the 9,086 reports break down

By recorded gender -- every report on file for Spitz - German Pomeranian, no filtering.

Annual report volume

Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 555 416.25 277.5 138.75 0 2019 2020 2021 2022 2023 2024 2025 2026 Reports filed Death-coded reports
Annual report volume for Spitz - German Pomeranian drawn from FDA CVM filings.

Data updated September 2026

The verdict

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Spitz - German Pomeranian ranks #23 of 510 by total reports (9,086) and #131 of 275 by death-coded share (4.9%). National dual: Retriever - Labrador is #1 of 510 by total adverse-event reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).

93,675
Retriever - Labrador reports (#1)
99.0%
Atlantic Salmon (Salmo salar) death share (#1)
#23
This breed, reports of 510
#131
This breed, death share of 275

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Spitz - German Pomeranian has 9,086 reports now versus 8,994 in that prior snapshot: 92 more (1.0%).

Report change
+92
Death-coded reports
+3
Death-coded share
−0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Spitz - German Pomeranian changes

Total Reports

9,086

Highest-reported breed

Deaths Reported

449

of 9,086 reports

Death-coded share of reports

4.9%

Above-median death-coded share

Avg Age at Report

5.9 yr

5.2 kg avg weight

Breed Safety Scorecard

C+ (63/100)

A weighted composite across 4 of 4 dimensions, each benchmarked against every tracked breed with at least 200 reports (n=185). Dimensions with insufficient data drop out and their weight redistributes to the rest, so a missing input never silently deflates the score.

Death rate D
4.9%

Share of reports coded as a fatality

Euthanasia rate B+
1.5%

Share of reports resulting in euthanasia

Full recovery rate B+
35.6%

Share of reports coded "Recovered/Normal"

5-year trend C
+2%

Change in annual report volume over the last 5 complete years

Death-Coded Outcome Share

Spitz - German Pomeranian death-coded reports 4.9%
Cross-breed median

4.9% of 9,086 spitz - german pomeranian reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Where Spitz - German Pomeranian's death-coded share sits among indexed breeds

Death-coded share of FDA CVM reports, breeds with ≥50 reports (July 2026 extract)

5% 52nd percentile Higher share than 52% of 275 indexed breeds

5%–10%: 1 indexed breeds (0%). This entry sits in this band. 20%–25%: 2 indexed breeds (1%). Above this entry. 25%–30%: 3 indexed breeds (1%). Above this entry. 30%–35%: 4 indexed breeds (1%). Above this entry. 35%–40%: 5 indexed breeds (2%). Above this entry. 40%–45%: 6 indexed breeds (2%). Above this entry. 45%–50%: 3 indexed breeds (1%). Above this entry. 50%–55%: 7 indexed breeds (3%). Above this entry. 55%–60%: 7 indexed breeds (3%). Above this entry. 60%–65%: 21 indexed breeds (8%). Above this entry. 65%–70%: 11 indexed breeds (4%). Above this entry. 70%–75%: 15 indexed breeds (5%). Above this entry. 75%–80%: 13 indexed breeds (5%). Above this entry. 80%–85%: 11 indexed breeds (4%). Above this entry. 85%–90%: 12 indexed breeds (4%). Above this entry. 90%–95%: 12 indexed breeds (4%). Above this entry. 95%–100%: 142 indexed breeds (52%). Above this entry. Spitz - German Pomeranian 5% 100% every breed with ≥50 FDA reports, bucketed by value

Each bar is a band; taller bars hold more indexed breeds. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source FDA Center for Veterinary Medicine, openFDA adverse event extract (PlainBreed) · July 2026 extract

This histogram uses the same ≥50-report cohort as the highest death-coded share ranking. A higher share means more of this breed's reported events were death-coded, not a mortality rate for living animals.

Spitz - German Pomeranian among report-volume vs. death-rate peers

Every breed shown has at least 50 filed reports. Volume reflects how often a breed is reported, not how common it is; death rate is the share of a breed's own reports coded as a death outcome.

Source: FDA openFDA Animal & Veterinary Adverse Events database 2×2 strategic matrix plotting 30 entities by Total Reports (X) and Death Rate (%) (Y), with a crosshair dividing the plot into four quadrants. High volume, high death rateLow volume, high death rateHigh volume, low death rateLow volume, low death rate 020,00040,00060,00080,000100,000 0%5%10%15% Total Reports Death Rate (%) Spitz - German Pomeranian vs. all breeds, report volume and death-coded share Retriever - Labrador-93675, 3.7%Crossbred Canine/dog-70591, 3.2%Domestic Shorthair-65226, 7.2%Dog (unknown)-48820, 8.8%Retriever - Golden-35980, 3.7%Shepherd Dog - German-32220, 4.4%Chihuahua-31521, 4.2%Terrier - Yorkshire-24924, 3.7%Shih Tzu-24405, 3.6%Boxer (German Boxer)-19405, 4.4%Beagle-17970, 3.6%Pit Bull-17865, 3.1%Shepherd Dog - Australian-16274, 3.7%Terrier (unspecified)-14058, 3.1%Maltese-13940, 3.2%Dachshund (unspecified)-13512, 4.6%Cat (unknown)-13248, 9.3%Terrier - Jack Russell-10423, 3.7%Collie - Border-10130, 4.3%Siberian Husky-9811, 4.5%Domestic Longhair-9615, 7%Pug-9224, 5.2%Spitz - German Pomeranian-9086, 4.9%Terrier - Bull - American Pit-8769, 4.7%Cattle Dog - Australian (blue heeler, red heeler, Queensland cattledog)-7871, 3.6%Terrier - Boston-7737, 4.5%Spaniel - Cocker American-7640, 4%Domestic (unspecified)-7576, 13.4%Poodle (unspecified)-7534, 3.4%Schnauzer - Miniature-7513, 4.4%
Source: FDA openFDA Animal & Veterinary Adverse Events database
Average weight at time of report: 5.2 kg (11.5 lbs)

Top Reported Reactions

Vomiting 2,125
Lethargy (see also Central nervous system depression in 'Neurological') 1,072
Lack of efficacy (ectoparasite) - flea 1,011
Emesis 931
Diarrhoea 711
Seizure NOS 551
Anorexia 386
Lack of efficacy - NOS 374
Death 278
Behavioural disorder NOS 265
Ataxia 263
Lack of efficacy (endoparasite) - hookworm 254
Not eating 249
Shaking 246
Emesis (multiple) 246

Most Referenced Drugs

Milbemycin Oxime + Spinosad 1,771
Spinosad 1,241
Afoxolaner 574
Ivermectin + Pyrantel As Pamoate Salt 505
Pyrantel Pamoate;Sarolaner 453
Fluralaner Chew Tablets 411
Moxidectin 365
Fluralaner 13.64% 12-Week Chew 332
Nitenpyram 265
Selamectin 216
Milbemycin Oxime + Praziquantel 214
Sarolaner 210
Imidacloprid + Moxidectin 176
Maropitant Citrate 163
Oclacitinib Maleate 150

Outcome Breakdown

Recovered/Normal
3,237 (38.6%)
Outcome Unknown
2,573 (30.7%)
Ongoing
1,806 (21.5%)
Recovered with Sequela
328 (3.9%)
Died
310 (3.7%)
Euthanized
139 (1.7%)

Gender Distribution

Male 4,580 (50.4%)
Female 4,271 (47.0%)
Unknown 203 (2.2%)
Mixed 32 (0.4%)

Reports by Year

Year Reports Trend
2010 387
2011 510
2012 766
2013 785
2014 759
2015 691
2016 661
2017 680
2018 576
2019 555
2020 456
2021 455
2022 376
2023 410
2024 482
2025 464
2026 73

Spitz - German Pomeranian: high-volume FDA adverse-event cohort

Signature read: 9,086 reports place Spitz - German Pomeranian in the upper third of breed filing volume (#23 of 510). According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, Spitz - German Pomeranian sits at #23 of 510 by report volume among all breeds and #20 of 298 among dog breeds, with 9,086 reports and 449 (4.9%) death-coded. On death-coded share among breeds with ≥50 reports, it ranks #131 of 275. Mean age at report: 5.9 years, average weight 5.2 kg (11.5 lbs).

Top reported signs: Vomiting (2,125), Lethargy (see also Central nervous system depression in 'Neurological') (1,072), Lack of efficacy (ectoparasite) - flea (1,011). Most-referenced drug: Milbemycin Oxime + Spinosad (1,771 reports), followed by Spinosad (1,241) and Afoxolaner (574).

Outcome coding on 8,393 status-recorded reports is dominated by Recovered/Normal (38.6%). Annual submissions ranged 73-2,026 across 17 years on file.

Dog Breeds With a Similar Report Volume

Showing 6 of 297 dog breeds in our dataset, ranked by closest report volume.

Pug
9,224 reports · 5.2% death-coded
Terrier - Bull - American Pit
8,769 reports · 4.7% death-coded
Siberian Husky
9,811 reports · 4.5% death-coded
Collie - Border
10,130 reports · 4.3% death-coded
Cattle Dog - Australian (blue heeler, red heeler, Queensland cattledog)
7,871 reports · 3.6% death-coded
Terrier - Jack Russell
10,423 reports · 3.7% death-coded

Nationwide breeds with similar profiles

High-volume peer sets for Spitz - German Pomeranian drawn from openFDA outside the Dog family so the neighborhoods are not species containment (the similar-volume list above stays within species).

Similar death-coded share

Nearest other-species breeds with ≥50 reports (4.9% death-coded here).

Scottish Fold Longhair 4.8% · Cat Egyptian Mau 5.3% · Cat Bengal 4.6% · Cat Siberian 4.2% · Cat

Similar average weight

Nearest other-species breeds by reported average weight (5.2 kg here).

American Shorthair 5.2 kg · Cat European Lynx 5.3 kg · Cat Russian 5.1 kg · Cat American Curl Shorthair 5.1 kg · Cat

What to do with this dog

A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.

Frequently Asked Questions

How many FDA adverse event reports involve Spitz - German Pomeranian? ▼
There are 9,086 adverse event reports involving Spitz - German Pomeranian in the FDA database, of which 449 were death-coded (4.9% of those reports). That is a share of REPORTED events, not a mortality rate for the breed: adverse events reach the FDA when something goes wrong, so the denominator is reports, never the population of animals. According to the same FDA CVM extract, Spitz - German Pomeranian ranks #23 of 510 by report volume among all breeds PlainBreed indexes (#20 of 298 among dog breeds).
Where does Spitz - German Pomeranian sit among other breeds in PlainBreed's corpus? ▼
According to FDA CVM report volume, Spitz - German Pomeranian is #23 of 510 breeds indexed on PlainBreed (same ordering as the most-reported-breeds ranking). Inside Dog, it is #20 of 298. Among breeds with at least 50 reports, its death-coded share ranks #131 of 275 (same cohort as highest-death-rate). These are placement ranks in the reporting corpus, not clinical risk scores.
What are the most common adverse reactions reported for Spitz - German Pomeranian? ▼
The most commonly reported adverse reactions for Spitz - German Pomeranian are Vomiting (2,125 reports), Lethargy (see also Central nervous system depression in 'Neurological') (1,072 reports), Lack of efficacy (ectoparasite) - flea (1,011 reports), Emesis (931 reports), Diarrhoea (711 reports).
What drugs are most frequently associated with Spitz - German Pomeranian adverse events? ▼
The drugs most frequently referenced in Spitz - German Pomeranian adverse event reports are Milbemycin Oxime + Spinosad (1,771 reports), Spinosad (1,241 reports), Afoxolaner (574 reports), Ivermectin + Pyrantel As Pamoate Salt (505 reports), Pyrantel Pamoate;Sarolaner (453 reports).
What is the average age of Spitz - German Pomeranian in adverse event reports? ▼
The average age of Spitz - German Pomeranian at the time of adverse event reports is 5.9 years, with an average weight of 5.2 kg (11.5 lbs).

Compare a breed's report volume against how common the breed is before drawing conclusions. See our methodology for how the death-coded share and rankings are computed, or read breed-specific reporting patterns and FDA CVM reporting.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Spitz - German Pomeranian (Dog), extract as of July 2026 extract. 9,086 reports · 449 death-coded (4.9% of reports, not a mortality rate) · #23 of 510 by volume.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →